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To test if the CRISPR/Cas9 system can mediate targeted gene disruption in *Xenopus laevis*, we targeted *ptf1a/p48* and *tyrosinase* in this species and found that in addition to high sequence disruption efficiency, clear phenotypes were observed in G0 embryos. *ptf1a/p48-*targeted *X. laevis* embryos can mimic *Xenopus tropicalis ptf1a/p48-*null mutant tadpoles with respect to the loss of *pdip* expression. Simultaneous disruption of two *X. laevi*s *tyrosinase* homeologs leads to almost full albinism. Our data indicate that CRISPR/Cas9 system is a simple and efficient tool for targeted gene disruption in *X. laevis.* It can be used for phenotype analysis in G0 embryos.

Since its introduction to modern biology in the 1950s, *X. laevis* has played a central role in most disciplines of biomedical research including developmental biology, biochemistry, and molecular biology \[[@CR1]\]. Its allotetraploid genome represents a common polyploidy in amphibians, which challenges genetic studies on this species \[[@CR2]\]. Fortunately, by the mid 1990s, *X. tropicalis*, the only diploid species in the *Xenopus* genus, was adopted as a genetically tractable complement to the classic model *X. laevis*. Together, the two frog species provide a unique and powerful system for addressing genome duplication/evolution, functional genomics, and human disease modelling at the post-genomic era \[[@CR1]\].

Gene knockdown in *X. laevis* has been largely dependent on antisense Morpholino oligomers since 2000, which suffers from some off-target effects \[[@CR3]\]. A recent systematic analysis reveals poor phenotypic correlation between published Morpholino-induced morphants and mutant lines in zebrafish \[[@CR4]\], further highlighting the off-target effects of Morpholino oligomers. Transcription activator-like effector nuclease (TALEN) was shown effective for targeted gene disruption in *X. laevis* G0 embryos \[[@CR1],[@CR5]-[@CR7]\]. With the establishment of efficient targeted gene disruption in *X. tropicalis* using the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated 9 (CRISPR/Cas9) system \[[@CR8]\], it is worth addressing if this simple method applies to *X. laevis*.

CRISPR/Cas9 mediated disruption of *ptf1a/p48* in *X. laevis* G0 embryos phenocopies *X. tropicalis ptf1a/p48* mutants {#Sec2}
----------------------------------------------------------------------------------------------------------------------

The basic helix-loop-helix transcription factor Ptf1a/p48 is a key regulator early for pancreatic precursor specification and late for exocrine pancreas formation \[[@CR9],[@CR10]\]. Our previous studies indicate that targeted disruption of *X. tropicalis ptf1a/p48* in G0 embryos using either TALENs \[[@CR5]\] or CRISPR/Cas9 \[[@CR8]\] leads to inhibition of pancreas formation as indicated by reduction of pancreas-specific marker gene *pdip* expression. These data are consistent with the *X. laevis* morphants \[[@CR10]\] and *Ptf1a/p48* knockout mice \[[@CR9]\]. Here, using our previously generated CRISPR/Cas9-targeted founder frogs, we established a *X. tropicalis ptf1a/p48* mutant line. Unlike *Ptf1a/p48-*null mutant mice that can survive whole gestation \[[@CR9]\] likely due to mother supply of blood/nutrition and die at birth, the free-swimming *X. tropicalis ptf1a/p48* homozygous mutant tadpoles cannot develop to froglets and all died during feeding stages (around stages 47--48). Those collected at stage 43 showed complete absence of *pdip* expression (Figure [1](#Fig1){ref-type="fig"}A, C), while heterozygous tadpoles are indistinguishable from wild type siblings (Figure [1](#Fig1){ref-type="fig"}B, D), which is similar to the phenotype of *Ptf1a/p48* knockout mice \[[@CR9]\]. The mutant phenotype obtained here also verified the reliability of previous observations on *X. laevis* morphants \[[@CR10]\].Figure 1*pdip* expression is undetectable in *X. tropicalis ptf1a/p48*-null mutant tadpoles. Whole-mount in situ hybridization analysis of *pdip* expression in F2 *X. tropicalis ptf1a/p48* mutant tadpoles (stage 43). Ventral-lateral view, head to the left. (**A**, **C**) About 22% homozygous tadpoles showed complete absence of *pdip* expression. (**B**, **D**) The remainder uniformly showed strong *pdip* expression, suggesting normal pancreas development in *ptf1a/p48* heterozygous tadpoles.

Given the allotetraploid genome of *X. laevis*, every gene might have two pairs of homeologs. For *ptf1a/p48* allele, only one cDNA sequence can be found from current databases (GenBank: DQ007931.1). We designed two gRNAs targeting the first exon of this *X. laevis ptf1a/p48* locus, namely *ptf1a/p48-*T1 and *ptf1a/p48-*T2 (Additional file [1](#MOESM1){ref-type="media"}: Table S1). First we injected Cas9 mRNA together with these two gRNAs either alone or in combination into animal pole of 1-cell stage *X. laevis* embryos and assessed their indel-inducing capacity via the PCR/sequencing protocol (Additional file [1](#MOESM1){ref-type="media"}: Table S2). Based on our experience with *X. tropicalis* embryos, we set the doses of both Cas9 mRNA and gRNAs at 300 pg/embryo, which were proven optimal as on one hand efficient targeted gene disruption was obtained (Figure [2](#Fig2){ref-type="fig"}) and on the other hand no morphological malformation was observed in injected embryos. Overall, the targeted sequence disruption efficiency is above 50% (Figure [2](#Fig2){ref-type="fig"}), which is comparable to that in *X. tropicalis* \[[@CR8]\]. It should be noted that slightly more than 1/3 of the disruption did not cause reading frame shift (Figure [2](#Fig2){ref-type="fig"}).Figure 2CRISPR/Cas9 is effective in targeting *X. laevis ptf1a/p48.* DNA sequencing data reveal the indel-inducing efficiencies of *ptf1a/p48*-T1 and *ptf1a/p48*-T2 in *X. laevis* embryos. For all panels, the wild-type sequence is shown at the top with the target site highlighted in yellow and the PAM sequence in blue. Red dashes indicate deletions (−) and lowercase letters in red indicate insertions (+).

Next, we evaluated the pancreas development in injected embryos by whole mount in situ hybridization with a *pdip* probe. Similar to the observation in *ptf1a/p48-*targeted *X. tropicalis* G0 embryos \[[@CR8]\], severe inhibition of *pdip* expression was observed in all three injection groups (Figure [3](#Fig3){ref-type="fig"}). For reasons unknown, in spite of their lower sequence disruption efficiency in comparison to the individually injected embryos (Figure [2](#Fig2){ref-type="fig"}), *ptf1a/p48-*T1 and -T2 co-injected embryos displayed stronger pancreatic phenotype with quite a few of them showing almost complete absence of *pdip* expression reminiscent of *X. tropicalis ptf1a/p48-*null mutants (Figure [3](#Fig3){ref-type="fig"}K, N and Figure [1](#Fig1){ref-type="fig"}A, C). Taken together, these data indicate that CRISPR/Cas9 system is effective in *X. laevis*. For *ptf1a/p48*, one gRNA is sufficient to cause an obvious pancreatic phenotype in *X. laevis* G0 embryos.Figure 3*ptf1a/p48*-targeted *X. laevis* G0 tadpoles showed reduction of *pdip* expression. Whole-mount in situ hybridization analyses of *pdip* expression (stage 42). Ventral-lateral view, head to the left. (**A**, **B**) Wild type *X. laevis* tadpoles. (**C**, **E**) Severe reduction. (**D**, **F**) Mild reduction. (**G**, **I**) Severe reduction. (**H**, **J**) Mild reduction. (**K**, **N**) Almost complete absence. (**L**, **O**) Severe reduction. (**M**, **P**) Mild reduction.

Simultaneous disruption of two *X. laevis tyrosinase* homeologs leads to albinism {#Sec3}
---------------------------------------------------------------------------------

To further test if CRISPR/Cas9 is a robust tool for gene targeting in *X. laevis*, we chose to target *tyrosinase*. There are two homeologs for *X. laevis tyrosinase*, *tyra* and *tyrb* \[[@CR7]\]. A previous study showed that one pair of TALENs targeting a highly conserved region of the two homeologs was sufficient to induce albinism in *X. laevis* \[[@CR6]\]. As no suitable gRNA targeting sites can be found in this conserved region for both homeologs, we have to design two gRNAs (*tyra*-T and *tyrb*-T) to target *tyra* and *tyrb*, respectively (Additional file [1](#MOESM1){ref-type="media"}: Table S1). Again, we injected Cas9 mRNA (300 pg/embryo) with these two gRNAs either alone or in combination (300 pg/embryo for each gRNA) into the animal pole of *X. laevis* fertilized eggs. PCR/sequencing data indicate that both gRNAs are very effective with targeted sequence disruption efficiencies from 87.5% up to 100% (Figure [4](#Fig4){ref-type="fig"}). The *tyra*-T and *tyrb*-T co-injected tadpoles showed severe reduction of pigmentation (Figure [5](#Fig5){ref-type="fig"}B, E), with 37% (37/100) of them showing almost full albinism (Figure [5](#Fig5){ref-type="fig"}A, D), which is stronger than TALENs-induced phenotype in *X. laevis* \[[@CR6],[@CR7]\] and CRISPR/Cas9-induced phenotype in *X. tropicalis* \[[@CR8]\]. An independent injection led to similar results. In contrast, although the sequence disruption efficiency remained high (Figure [4](#Fig4){ref-type="fig"}), individual injection of either *tyra*-T or *tyrb*-T did not cause any obvious alteration on embryonic pigmentation (Figure [5](#Fig5){ref-type="fig"}H, I, K, L), indicating the functional redundancy of *tyra* and *tyrb.* In sum, these data further confirm that CRISPR/Cas9 system is effective in *X. laevis.* Distinct homeologs of *X. laevis* genes can be easily disrupted by application of two gRNAs.Figure 4CRISPR/Cas9 is effective in targeting *X. laevis tyrosinase.* DNA sequencing data reveal the indel-inducing efficiencies of *tyra*-T and *tyrb*-T in *X. laevis* embryos. For all panels, the wild-type sequence is shown at the top with the target site highlighted in yellow and the PAM sequence in blue. Red dashes indicate deletions (−) and lowercase letters in red indicate insertions (+). The left two panels show data from *tyra*-T and *tyrb*-T co-injection and right two panels indicate individual injection results.Figure 5Simultaneous disruption of two *X. laevis tyrosinase* homeologs leads to albinism in G0 tadpoles (stage 42). Lateral view, head to the left. (**A**, **D**) Almost full albinism. (**B**, **E**) Severe inhibition of pigmentation. (**C**, **F**) Almost normal. (**G**, **J**) Wild type. (**H**, **I**, **K**, **L**) Almost normal.

Due to Morpholino's potential off-target effects, a recent study recommends mutant phenotypes as the standard metric to define gene function in zebrafish \[[@CR4]\]. Our previous study did not detect any CRISPR/Cas9-induced off-target effects in *X. tropicalis* \[[@CR8]\]. The issue of CRISPR/Cas9's off-target effects in *X. laevis* remains to be defined. Nevertheless, our data demonstrate that CRISPR/Cas9 is equally a superb tool for targeted gene disruption in *X. laevis* as in *X. tropicalis*. It can be used for an immediate phenotype evaluation in *X. laevis* G0 embryos. It should be noted that the allotetraploid genome and longer generation time (1--2 years) of *X. laevis* makes it impractical to do genetic research. For establishment of stable knockout lines, we recommend to use the diploid frog *X. tropicalis* that has much shorter generation time (4--6 months).
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Additional file 1: Table S1.Oligonucleotides used to construct gRNA expression templates. **Table S2.** PCR primers used to amplify the targeted loci.
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